PURE Bioscience, Inc. (PURE)
- Previous Close
0.0800 - Open
0.0670 - Bid --
- Ask --
- Day's Range
0.0670 - 0.0700 - 52 Week Range
0.0600 - 0.1700 - Volume
8,088 - Avg. Volume
27,374 - Market Cap (intraday)
7.83M - Beta (5Y Monthly) 0.06
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date Jun 12, 2024 - Jun 17, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.
www.purebio.com11
Full Time Employees
July 31
Fiscal Year Ends
Sector
Industry
Recent News: PURE
Performance Overview: PURE
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PURE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PURE
Valuation Measures
Market Cap
7.83M
Enterprise Value
9.13M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.80
Price/Book (mrq)
--
Enterprise Value/Revenue
4.44
Enterprise Value/EBITDA
-2.65
Financial Highlights
Profitability and Income Statement
Profit Margin
-177.20%
Return on Assets (ttm)
-112.66%
Return on Equity (ttm)
-977.21%
Revenue (ttm)
2.06M
Net Income Avi to Common (ttm)
-3.65M
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
557k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.54M
Company Insights: PURE
PURE does not have Company Insights